The primary antibodies were as follows: B220 (Rat, 1:200, Biolegend #103202), CD11b (Rabbit, 1:200, Abcam #133357), CD3 (Rabbit, 1:200, Abcam #16669), CD4 (Rat, 1:200, ThermoFisher #14-9766-82), CD8 (Rat, 1:100, ThermoFisher, #14-0808-82), IBA1 (Rabbit, 1:200, VWR #100369-764), and MPO (Rabbit, 1:500, Abcam, #ab208670)
Zhou YF, Zhu YW, Wang YW, Liang XY, Jiang QY, Wu DD (2025) Diallyl disulfide in oncotherapy: molecular mechanisms and therapeutic potentials
T he half-life of a drug, represented by the symbol T/2, is defined in different ways
The 28-day discard rule is also underestimated
This method not only reduces patient suffering but also enables timely reflection of tumor responses to treatment, helping physicians adjust treatment plans and improve therapeutic outcomes